Abstract
Though HPV vaccines have been available for several years, the HPV vaccination coverage in the U.S. remains low. Recent estimates indicate that only 60% of teens aged 13-17 received one or more doses of the vaccine and only about 40% of teens are completing the recommended dosing series. A substantial opportunity exists to target college- and graduate school-aged persons for HPV vaccination because many will not have completed, or started, their vaccinations. For every year that the vaccination rate for the series completion remains at 30-40%, there will be an estimated 4,400 new cases of cervical cancer and an estimated 1,400 cervical cancer-related deaths.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
